急性GVHD的非经典表现
急性移植物抗宿主病(GVHD)的经典靶器官为肠道、肝脏和皮肤,但越来越多证据显示中枢神经系统、肺、卵巢和睾丸、胸腺、骨髓及肾脏也可受累。本文综述啮齿动物模型和患者中急性GVHD非经典表现的研究证据,并结合新兴GVHD治疗进行讨论,以助于改善异基因造血细胞移植(allo-HCT)后患者结局。
要点
- 急性GVHD除肠道、肝脏、皮肤外,还可累及中枢神经系统、肺、性腺、胸腺、骨髓和肾脏。
- 非经典靶器官损伤表现不明显或易与药物毒性混淆,临床需提高识别意识。
- 理解非经典GVHD靶器官受累有助于改善allo-HCT后患者预后。
核心结论
- 越来越多证据表明急性GVHD可累及中枢神经系统、肺、卵巢和睾丸、胸腺、骨髓及肾脏等非经典靶器官。
- 更好地理解非经典GVHD靶器官受累可能有助于改善allo-HCT后患者结局。
研究设计与样本
- 综述类文章,汇总啮齿动物模型和患者中急性GVHD非经典表现的相关证据。
主要发现
- 急性GVHD经典靶器官为肠道、肝脏和皮肤,损伤表现为腹泻、胆红素升高和皮疹,相对易于临床检测。
- 非经典靶器官的急性损伤表现较不明显或更难以与药物毒性区分,包括中枢神经系统、肺、卵巢和睾丸、胸腺、骨髓及肾脏。
临床怎么用
- 临床医生在allo-HCT后应关注非经典GVHD靶器官受累的可能,注意与药物毒性鉴别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute graft-versus-host disease (GVHD) is a major life-threatening complication after allogeneic hematopoietic cell transplantation (allo-HCT). The classical target organs of acute GVHD include the intestines, liver, and skin. The damage of these organs is relatively easy to detect for the clinician as diarrhea, increased bilirubin, and rash. However, there is increasing evidence that other organs, where the acute damage is less apparent or more difficult to distinguish from drug toxicity, such as the central nervous system, lungs, ovaries and testis, thymus, bone marrow, and kidney, can be target organs of acute GVHD. Here, we review current evidence for nonclassical manifestations of acute GVHD in rodent models and in patients and discuss them in the context of novel emerging therapies for GVHD. A better understanding of the involvement of nonclassical GVHD target organs may help to improve patient outcomes after allo-HCT.
引用
- Zeiser R, Teshima T. Nonclassical manifestations of acute GVHD. Blood. 2021. PMID: 34482399. doi:10.1182/blood.2021012431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。